Lacosamide
Product Images NDC 0121-0992

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 0121-0992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Laco-structure (Lacosamide Oral Solution Cv 1)

Chemical structure of lacosamide, showing its molecular configuration with labeled atoms and bonds typical for the compound used as an antiepileptic agent.*

FDA Label Image

Laco-fig-1 (Lacosamide Oral Solution Cv 2)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 Days from Baseline to the Maintenance Phase by Dose' showing seizure reduction percentages in three studies. The chart compares placebo versus Lacosamide doses (200, 400, 600 mg/day) with seizure reduction percentages increasing with dose, indicating higher median percent reductions for Lacosamide groups across all studies.*

FDA Label Image

Laco-fig-2 (Lacosamide Oral Solution Cv 3)

A line graph showing the proportion of patients by responder rate for Lacosamide and placebo groups in studies 2, 3, and 4. The x-axis represents the percent of patients, and the y-axis shows responder rate (equal to or greater) indicating improvement or worsening. Four lines compare placebo (solid line) and Lacosamide at 200 mg/day, 400 mg/day, and 600 mg/day dosages (various dashed lines).*

FDA Label Image

Pai Logo (Lacosamide Oral Solution Cv 4)

FDA Label Image

Pai Logo (Lacosamide Oral Solution Cv 5)

FDA Label Image

5 mL (Lacosamide Oral Solution Cv 6)

Label for Lacosamide oral solution USP 50 mg/5 mL, delivered in a 5 mL dose. The label includes the NDC 0121-0992-05 and states that the package is not child-resistant, advising to see the insert for Rx use. It is packaged by Pharmaceutical Associates, Inc., Greenville, SC.*

FDA Label Image

10 mL (Lacosamide Oral Solution Cv 7)

Lacosamide Oral Solution USP 100 mg/10 mL label showing drug strength, volume, and a barcode. The label specifies non-child-resistant packaging, directs users to the insert for prescription information, and lists Pharmaceutical Associates, Inc. in Greenville, SC, as the packager with lot and expiration date details.*

FDA Label Image

15 mL (Lacosamide Oral Solution Cv 8)

Lacosamide oral solution USP 150 mg/15 mL label showing the volume delivered, NDC number, and concentration. The label states the package is not child-resistant and includes a barcode, lot number, expiration date, and manufacturer information as Pharmaceutical Associates, Inc., Greenville, SC 29605.*

FDA Label Image

20 mL (Lacosamide Oral Solution Cv 9)

Lacosamide Oral Solution USP 200 mg/20 mL label, displaying the drug name, strength, and dosage form. The label notes it delivers 20 mL and is not child-resistant. It includes the NDC 0121-3968-74 and is labeled by PAI Holdings, LLC dba PAI Pharma. Additional packaging details and expiration date are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.